Why is Godavari Drugs falling/rising?

As of 21-Aug, Godavari Drugs Ltd is experiencing a price increase, currently at 84.16, reflecting a change of 0.96 or 1.15% upward. Despite this recent uptick, the stock has shown a negative performance over the past week and month, with declines of 0.99% and 4.96%, respectively. The stock is currently trading below all its moving averages, indicating a bearish trend. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 52.94% compared to the 5-day average. While the stock is trading at a discount compared to its peers and has a relatively attractive valuation with a ROCE of 12.3, it has also faced negative results over the last three quarters, with profits down by 41.2%. This combination of factors suggests that while there is a slight rebound, the overall sentiment remains cautious.
In the broader market context, the stock's recent performance contrasts with the Sensex, which has gained 1.74% over the past week. Godavari Drugs has underperformed the benchmark significantly, with a year-to-date return of -23.04% compared to the Sensex's positive 4.94%. This underperformance is further highlighted by the stock's negative returns over the past year and its inability to generate positive momentum in the near term. The weak long-term fundamentals, including a high Debt to EBITDA ratio and declining operating profits, contribute to a challenging outlook for the stock, despite the recent price increase.